B-Raf inhibitor 1,
1093100-40-3,
CHEMBL1197798,
N1-(4-Chlorophenyl)-6-methyl-N5-[3-(9H-purin-6-yl)-2-pyridinyl]-1,5-isoquinolinediamine,
N5-(3-(9H-purin-6-yl)pyridin-2-yl)-N1-(4-chlorophenyl)-6-methylisoquinoline-1,5-diamine,
1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine,
N~1~-(4-Chlorophenyl)-6-Methyl-N~5~-[3-(7h-Purin-6-Yl)pyridin-2-Yl]isoquinoline-1,5-Diamine,
B-Rafinhibitor1,
3idp,
B-raf,
B-Raf inhibitor1,
L1E,
SCHEMBL15215289,
SCHEMBL18155155,
BDBM35327,
EX-A485,
pyridylpurine aminoisoquinoline, 1,
BCP09276,
KS-00001D8H,
BDBM50165861,
MFCD22571725,
ZINC39300628,
AKOS026674009,
AKOS032960273,
CS-2182,
1,5-IsoquinolinediaMine, N1-(4-chlorophenyl)-6-Methyl-N5-[3-(9H-purin-6-yl)-2-pyridinyl]-,
NCGC00378697-03,
AC-30299,
AK198800,
HY-14177,
J3.552.293J,
A14122,
J-690027,
N-(4-Chlorophenyl)-5-[[3-(9H-purine-6-yl)-2-pyridyl]amino]-6-methylisoquinoline-1-amine,
N1-(4-chlorophenyl)-6-methyl-N5-[3-(9H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine,
B-Raf inhibitor,
B1172,
3-bromo-N-methyl-4,5-dihydro-1,2-oxazol-5-amine,